Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (3): 288-292,295    DOI: 10.19485/j.cnki.issn2096-5087.2025.03.016
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
高尿酸血症患者胫前动脉粥样硬化的影响因素分析
孙露, 郑东, 张洪超
达州市中西医结合医院,四川 达州 635000
Influencing factors for anterior tibial artery atherosclerosis among patients with hyperuricemia
SUN Lu, ZHENG Dong, ZHANG Hongchao
Dazhou Integrated TCM & Western Medicine Hospital, Dazhou, Sichuan 635000, China
全文: PDF(881 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解高尿酸血症患者胫前动脉粥样硬化的影响因素,为预防高尿酸血症患者胫前动脉粥样硬化提供参考。方法 选择2020—2023年在达州市中西医结合医院就诊的≥18岁高尿酸血症患者为研究对象,通过电子病历收集人口学信息和血生化指标等资料,采用彩色多普勒超声评估胫前动脉粥样硬化情况;采用多因素logistic回归模型分析高尿酸血症患者胫前动脉粥样硬化的影响因素。结果 调查高尿酸血症患者1 105例,其中男性862例,占78.01%;女性243例,占21.99%。年龄≥60岁918例,占83.08%。病程≥10年457例,占41.36%。血尿酸水平MQR)为480.79(98.28)μmol/L。高尿酸血症患者胫前动脉粥样硬化314例,占28.42%。多因素logistic回归分析结果显示,体质指数(≥24.0 kg/m2,OR=1.597,95%CI:1.185~2.151)、长期吸烟史(有,OR=1.709,95%CI:1.153~2.534)、糖尿病(有,OR=1.517,95%CI:1.162~1.981)、血尿酸(≥480.79 μmol/L,OR=1.667,95%CI:1.131~2.457)、血肌酐(≥97 μmol/L,OR=1.685,95%CI:1.155~2.460)、空腹血糖(≥6.1 mmol/L,OR=1.528,95%CI:1.106~2.112)、纤维蛋白原(>4 g/L,OR=1.589,95%CI:1.091~2.315)、三酰甘油(≥1.7 mmol/L,OR=1.879,95%CI:1.226~2.881)是高尿酸血症患者胫前动脉粥样硬化的影响因素。结论 高尿酸血症患者胫前动脉粥样硬化主要与长期吸烟、糖尿病和血尿酸、血肌酐、空腹血糖、纤维蛋白原、三酰甘油水平高有关。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
孙露
郑东
张洪超
关键词 高尿酸血症胫前动脉粥样硬化影响因素    
AbstractObjective To analyze the influencing factors for anterior tibial artery atherosclerosis among patients with hyperuricemia, so as to provide insights into the prevention of anterior tibial artery atherosclerosis. Methods Patients aged 18 years and older with hyperuricemia in Dazhou Integrated TCM & Western Medicine Hospital were enrolled as research subjects from 2020 to 2023. Demographic information and blood biochemistry indicators were collected through electronic medical records. Anterior tibial artery atherosclerosis was evaluated by color Doppler ultrasound. Factors affecting anterior tibial artery atherosclerosis among patients with hyperuricemia were analyzed by a multivariable logistic regression model. Results A total of 1 105 patients with hyperuricemia were surveyed, including 862 males (78.01%) and 243 females (21.99%). There were 918 cases (83.08%) at the ages of 60 years and older, and 457 cases (41.36%) with a course of disease at 10 years and longer. The median level of blood uric acid was 480.79 (interquartile range, 98.28) μmol/L. There were 314 cases (28.42%) with anterior tibial artery atherosclerosis. Multivariable logistic regression analysis showed that body mass index (≥24.0 kg/m2, OR=1.597, 95%CI: 1.185-2.151), long-term smoking history (yes, OR=1.709, 95%CI: 1.153-2.534), diabetes mellitus (yes, OR=1.517, 95%CI: 1.162-1.981), serum uric acid (≥480.79 μmol/L, OR=1.667, 95%CI: 1.131-2.457), serum creatinine (≥97 μmol/L, OR=1.685, 95%CI: 1.155-2.460), fasting blood glucose (≥6.1 mmol/L, OR=1.528, 95%CI: 1.106-2.112), fibrinogen (>4 g/L, OR=1.589, 95%CI: 1.091-2.315) and triglycerides (≥1.7 mmol/L, OR=1.879, 95%CI: 1.226-2.881) were influencing factors for anterior tibial artery atherosclerosis among patients with hyperuricemia. Conclusion Anterior tibial artery atherosclerosis among patients with hyperuricemia is associated with long-term smoking, diabetes mellitus, serum uric acid, serum creatinine, fasting blood glucose, fibrinogen and triglycerides high level.
Key wordshyperuricemia    anterior tibial artery atherosclerosis    influencing factor
收稿日期: 2024-08-22      修回日期: 2024-12-03      出版日期: 2025-03-10
中图分类号:  R587.2  
作者简介: 孙露,本科,主治医师,主要从事超声诊断工作
通信作者: 郑东,E-mail:253169126@qq.com   
引用本文:   
孙露, 郑东, 张洪超. 高尿酸血症患者胫前动脉粥样硬化的影响因素分析[J]. 预防医学, 2025, 37(3): 288-292,295.
SUN Lu, ZHENG Dong, ZHANG Hongchao. Influencing factors for anterior tibial artery atherosclerosis among patients with hyperuricemia. Preventive Medicine, 2025, 37(3): 288-292,295.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.03.016      或      https://www.zjyfyxzz.com/CN/Y2025/V37/I3/288
[1] 林淑芃. 《中国高尿酸血症与痛风诊疗指南(2019)》解读[J].临床内科杂志,2020,37(6):460-462.
LIN S F.Interpretation of the 2019 Chinese Guideline for the Diagnosis and Treatment of Hyperuricemia and Gout[J].J Clin Intern Med,2020,37(6):460-462.(in Chinese)
[2] KIMURA Y,TSUKUI D,KONO H.Uric acid in inflammation and the pathogenesis of atherosclerosis[J].Int J Mol Sci,2021,22(22):1-19.
[3] 周正雅,柴玉琼,袁晶,等.成人血尿酸水平与冠状动脉粥样硬化性心脏病的关联分析[J].公共卫生与预防医学,2023,34(1):141-143.
ZHOU Z Y,CHAI Y Q,YUAN J,et al.Relationship between uric acid and coronary atherosclerotic heart disease in adults[J].J Pub Health Prev Med,2023,34(1):141-143.(in Chinese)
[4] 徐东,殷婷,谢旭品,等.血尿酸联合单核细胞趋化因子1对下肢动脉硬化闭塞患者的诊断价值[J].心脑血管病防治,2020,20(6):622-624,628.
XU D,YIN T,XIE X P,et al.Diagnostic value of serum uric acid combined with monocyte chemotactic protein-1 in patients with lower extremity arterial occlusion[J].Cardio-Cerebrovasc Dis Prev Treat,2020,20(6):622-624,628.(in Chinese)
[5] 中华医学会内分泌学分会.中国高尿酸血症与痛风诊疗指南(2019)[J].中华内分泌代谢杂志,2020,36(1):1-13.
Chinese Society of Endocrinology,Chinese Medical Association.Guideline for the diagnosis and management of hyperuricemia and gout in China(2019)[J].Chin J Endocrinol Metab,2020,36(1):1-13.(in Chinese)
[6] HOMMA S,HIROSE N,ISHIDA H,et al.Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians[J].Stroke,2001,32(4):830-835.
[7] 冯可欣,郑启健,吕康,等.血脂及血尿酸对颈动脉粥样硬化发生风险的交互作用研究[J].中国脑血管病杂志,2022,19(10):667-676.
FENG K X,ZHENG Q J,LYU K,et al.Interaction of blood lipid and serum uric acid on the risk of carotid atherosclerosis[J].Chin J Cerebrovasc Dis,2022,19(10):667-676.(in Chinese)
[8] 方堃,丁岩,霍康.超重/肥胖与血浆致动脉粥样硬化指数及其交互作用对45岁及以上人群2型糖尿病患病风险的影响[J].郑州大学学报(医学版),2023,58(4):489-493.
FANG K,DING Y,HUO K.Interaction between overweight/obesity and atherogenic index of plasma on risk of type 2 diabetes mellitus for population with age ≥45 years[J].J Zhengzhou Univ(Med Sci),2023,58(4):489-493.(in Chinese)
[9] 杨烁,于波.吸烟与他汀类药物疗效在冠状动脉粥样硬化中的相互影响[J].心血管康复医学杂志,2021,30(3):366-370.
YANG S,YU B.Interaction between smoking and statins in coronary atherosclerosis[J].Chin J Cardiovasc Rehabil Med,2021,30(3):366-370.(in Chinese)
[10] 姚翡,郁秋荣,龚叶,等.2型糖尿病并发高尿酸血症患者血尿酸与粒淋比、γ-谷氨酰转肽酶的相关性及HUA发生的因素[J].河北医科大学学报,2022,43(10):1147-1152.
YAO F,YU Q R,GONG Y,et al.Correlation between serum uric acid,neutrophil-to-lymphocyte ratio and γ-glutamyl transpeptidase in patients with type 2 diabetes mellitus complicated with hyperuricemia and the influencing factors of hyperuricemia[J].J Hebei Med Univ,2022,43(10):1147-1152.(in Chinese)
[11] LEE T S,LU T M,CHEN C H,et al.Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway[J].Redox Biol,2021,46:1-9.
[12] 王少慧,刘鉴文,曾志伟.老年2型糖尿病合并高尿酸血症患者糖化血红蛋白、胱抑素C水平及其与血尿酸、血肌酐相关性分析[J].中国现代医药杂志,2021,23(2):73-75.
WANG S H,LIU J W,ZENG Z W.Correlation analysis of glycated hemoglobin,cystatin C levels,and their relationship with serum uric acid and serum creatinine in elderly patients with type 2 diabetes mellitus complicated by hyperuricemia[J].MMJC,2021,23(2):73-75.(in Chinese)
[13] 刘淑党,林静娜,邱慧娜,等.2型糖尿病患者血尿酸水平与发生动脉粥样硬化性心血管疾病事件风险的影响研究[J].中国糖尿病杂志,2022,30(4):241-245.
LIU S D,LIN J N,QIU H N,et al.Effect of serum uric acid level on the risk of ASCVD in patients with type 2 diabetes mellitus[J].Chin J Diabetes,2022,30(4):241-245.(in Chinese)
[14] 范为群,罗文良,邵布勒,等.直接胆红素和血脂对颈动脉粥样硬化及颈动脉斑块发生风险的交互作用[J].预防医学,2020,32(6):563-568.
FAN W Q,LUO W L,SHAO B L,et al.The interaction between direct bilirubin and blood lipids on carotid atherosclerosis and carotid plaque[J].China Prev Med J,2020,32(6):563-568.(in Chinese)
[1] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[2] 徐光明, 张震, 叶小红. 2015—2024年临海市新报告HIV/AIDS病例晚发现及影响因素分析[J]. 预防医学, 2026, 38(1): 71-74.
[3] 夏子淇, 陈晴晴, 高四海, 吴矛矛. 温州市中小学生营养健康知识调查[J]. 预防医学, 2026, 38(1): 98-101,106.
[4] 陈慧, 苗姗姗, 刘宪峰, 张慧. 新疆生产建设兵团中小学生龋齿现况调查[J]. 预防医学, 2026, 38(1): 102-106.
[5] 吕婧, 徐欣颖, 乔颖异, 石兴龙, 岳芳, 刘营, 程传龙, 张宇琦, 孙继民, 李秀君. 浙江省发热伴血小板减少综合征流行特征及影响因素分析[J]. 预防医学, 2026, 38(1): 10-14.
[6] 陶桃, 张海芳, 凡鹏飞, 李秋华, 陈晓蕾. 丽水市老年肺结核患者治疗转归的影响因素分析[J]. 预防医学, 2025, 37(9): 892-896,902.
[7] 徐艳平, 闫晓彤, 姚丁铭, 徐越, 张雪海, 孙洁, 徐锦杭. 浙江省中老年人肺炎疫苗接种意愿的影响因素研究[J]. 预防医学, 2025, 37(9): 881-885.
[8] 姜艳, 李锦成, 许纯, 杨科佼, 杨文彬, 徐胜. 扬州市MSM人群艾滋病非职业暴露后预防知晓率调查[J]. 预防医学, 2025, 37(9): 903-906,912.
[9] 翟羽佳, 章涛, 古雪, 徐乐, 吴梦娜, 林君芬, 吴晨. 社区老年人认知衰弱现况调查[J]. 预防医学, 2025, 37(8): 762-766,772.
[10] 苏德华, 陈向阳, 李君, 赵丽娜, 张鹤美, 朱婷婷, 胡文雪, 赖江宜. 温州市新报告HIV/AIDS病例抗病毒治疗及时性分析[J]. 预防医学, 2025, 37(8): 804-808.
[11] 严青秀, 王炜, 郝晓刚, 高宇, 方春福, 张幸, 刘文峰. 2017—2023年衢州市肺结核患者未收治情况分析[J]. 预防医学, 2025, 37(8): 799-803.
[12] 王晓宇, 张志平, 董玉颖, 梁杰, 陈强. 老年人带状疱疹疫苗接种意愿的影响因素分析[J]. 预防医学, 2025, 37(8): 809-813.
[13] 王海琪, 张涵潇, 杨凤云, 国献丽, 范生荣, 张丽锋, 蒋泓. 嘉定区中学生抑郁情绪调查[J]. 预防医学, 2025, 37(8): 832-836.
[14] 成灵灵, 阎亚琼, 白增华, 张晓刚, 郝丽婷, 杨慧莹. 先天性甲状腺功能减退症患儿年龄别体质指数Z评分变化轨迹及影响因素[J]. 预防医学, 2025, 37(8): 858-863.
[15] 陈强, 郭震, 朱玮, 何晓庆, 朱斌斌. 金华市重点人群职业健康素养调查[J]. 预防医学, 2025, 37(7): 747-750,756.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed